ATE227771T1 - Pankreatische ribonuclease mutante und ihre verwendung - Google Patents

Pankreatische ribonuclease mutante und ihre verwendung

Info

Publication number
ATE227771T1
ATE227771T1 AT95830039T AT95830039T ATE227771T1 AT E227771 T1 ATE227771 T1 AT E227771T1 AT 95830039 T AT95830039 T AT 95830039T AT 95830039 T AT95830039 T AT 95830039T AT E227771 T1 ATE227771 T1 AT E227771T1
Authority
AT
Austria
Prior art keywords
mutant
pancreatic ribonuclease
ribonuclease
pancreatic
muteins
Prior art date
Application number
AT95830039T
Other languages
English (en)
Inventor
Alessio Guiseppe D
Donato Alberto Di
Renata Piccoli
Original Assignee
Univ Napoli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Napoli filed Critical Univ Napoli
Application granted granted Critical
Publication of ATE227771T1 publication Critical patent/ATE227771T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95830039T 1994-02-16 1995-02-15 Pankreatische ribonuclease mutante und ihre verwendung ATE227771T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940073A IT1271864B (it) 1994-02-16 1994-02-16 Muteine della ribonucleasi pancreatica e loro usi.

Publications (1)

Publication Number Publication Date
ATE227771T1 true ATE227771T1 (de) 2002-11-15

Family

ID=11402242

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95830039T ATE227771T1 (de) 1994-02-16 1995-02-15 Pankreatische ribonuclease mutante und ihre verwendung

Country Status (5)

Country Link
EP (1) EP0668349B1 (de)
AT (1) ATE227771T1 (de)
DE (1) DE69528784T2 (de)
ES (1) ES2186709T3 (de)
IT (1) IT1271864B (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389537A (en) * 1994-01-21 1995-02-14 Wisconsin Alumni Research Foundation Nuclease having altered specificity

Also Published As

Publication number Publication date
DE69528784D1 (de) 2002-12-19
EP0668349B1 (de) 2002-11-13
EP0668349A3 (de) 1996-08-28
EP0668349A2 (de) 1995-08-23
ITRM940073A1 (it) 1995-08-16
ITRM940073A0 (it) 1994-02-16
IT1271864B (it) 1997-06-09
ES2186709T3 (es) 2003-05-16
DE69528784T2 (de) 2003-07-17

Similar Documents

Publication Publication Date Title
DK0751959T3 (da) Modificerede polypeptider med forøget biologisk aktivitet
DE69113729D1 (de) Sauerstoff-Brennstoff-Brennereinheit und Betriebsweise.
IL119461A (en) 4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines
DE69434651D1 (de) Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
AU1916995A (en) 4-amino derivatives of mycophenolic acid with immunosuppressant activity
NO953597D0 (no) Rullestol med kledningsdeler
SI0745075T1 (en) 6-substituted mycophenolic and derivatives with immunosuppressive activity
FR2716786B1 (fr) Perfectionnements aux accoudoirs rabattables et aux sièges équipés de tels accoudoirs.
DE3888466D1 (de) 6-Arylaminomethylchinolin-Derivate und ihre Verwendung als Antitumorwirkstoff.
DE68922542D1 (de) Nichtlinearer Verstärker und nichtlineare Vor- und Nachverzerrungsanlage unter Verwendung derselben Schaltung.
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
DE3675876D1 (de) Appetit mildernde und gegen gastritis wirksame zusammensetzung.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE227771T1 (de) Pankreatische ribonuclease mutante und ihre verwendung
AU1747295A (en) 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
DE3786616D1 (de) Bacillus brevis-staemme und ihre verwendung.
AU1875395A (en) 4-amino derivatives of 5-substituted mycophenolic acid
DE3889542D1 (de) Kohlenaschen-modifizierung und reduktion.
NO953596D0 (no) Rullestol med kledningsdeler
DE69007931D1 (de) Akarizide zusammensetzung und ihre verwendung in der befallsbekämpfung.
DE69425061D1 (de) Verwendung von einer suspension auf der basis von sucralfatgel als antazidum
ATE66218T1 (de) 5-heterocyclisch substituierte-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
ES1024481U (es) Canape desmontable.
ATE80528T1 (de) Sauerstoffabsorptionsmittel und verwendung desselben.
ATE104945T1 (de) Alkyltetramethylcyclohexan-derivate und deren verwendung als duftstoffe.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties